BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33849755)

  • 21. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
    Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
    Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
    Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
    J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
    Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M
    Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
    Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
    J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering hydroa vacciniforme.
    Quintanilla-Martinez L; Fend F
    Blood; 2019 Jun; 133(26):2735-2737. PubMed ID: 31248873
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
    Xu Z; Lian S
    Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
    Zeng Y; Fu L; Jin H; Sun Q; Wang B
    Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection.
    Heo EP; Park SH; Kim TH
    Int J Dermatol; 2003 Jun; 42(6):476-9. PubMed ID: 12854510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease.
    Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A
    J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
    Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
    Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
    Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
    Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
    J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
    Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
    Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lupus erythematous presenting with hydroa vacciniforme-like eruption: mimicking Epstein-Barr virus-associated lymphoproliferative disorders.
    Noh TK; Haw S; Soung JH; Won CH; Chang S; Choi JH; Moon KC; Park YS; Lee MW
    J Dermatol; 2012 Dec; 39(12):1095-7. PubMed ID: 22937887
    [No Abstract]   [Full Text] [Related]  

  • 39. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
    Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
    Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
    Xie Y; Wang T; Wang L
    J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.